Attached files

file filename
8-K - FORM 8-K - Echo Therapeutics, Inc.ecte8k_apr292016.htm
EX-10.3 - FORM OF WARRANT - Echo Therapeutics, Inc.ex10-3.htm
EX-10.4 - PROMISSORY NOTE, DATED APRIL 29, 2016, ISSUED TO BEIJING YI TANG BIO SCIENCE & TECHNOLOGY, LTD. BY THE COMPANY. - Echo Therapeutics, Inc.ex10-4.htm
EX-3.1 - AMENDMENT TO CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS OF ITS SERIES F CONVERTIBLE PREFERRED STOCK. - Echo Therapeutics, Inc.ex3-1.htm
EX-10.2 - FORM OF NOTE - Echo Therapeutics, Inc.ex10-2.htm
Exhibit 10.5

PROMISSORY NOTE


$770,000
 
 
May 2, 2016

FOR VALUE RECEIVED, BEIJING YI  TANG BIO SCIENCE & TECHNOLOGY, LTD., (together with its successors and assigns, the “Borrower”), with its principal place of business at ROOM 1107, No.1 Building, No29 Nanmofang Road, Chaoyang District, Beijing 100022 P.R. China promises to pay to the order of ECHO THERAPEUTICS, INC. (together with any successors or assigns, the “Lender”) at the office of the Lender, the sum of Seven Hundred Seventy Thousand DOLLARS and ZERO cents ($770,000), together with interest on the unpaid balance and all other charges, as provided below.  Commencing on the date hereof, interest shall accrue on the unpaid principal balance outstanding from time to time at a rate per annum equal to The Wall Street Journal Prime Rate plus two percent, compounding monthly.   The Borrower shall pay all outstanding principal and interest on or before May 31, 2016.  To the extent permitted by applicable law, upon and after the occurrence of an Event of Default (whether or not the Lender has accelerated payment of this Note), interest on principal shall be payable on demand at a rate per annum equal to 12% per annum, compounding monthly.  This Note is issued as partial payment of the Purchase Price pursuant to Section 2.7 of the Securities Purchase Agreement, dated January 29, 2016, among Lender and the Purchasers named therein (the “Purchase Agreement”).  The occurrence of any Event of Default under this Note shall cause Borrower to be a Defaulting Purchaser under the Purchase Agreement, and Borrower shall be treated as a Defaulting Purchaser for all purposes under the Purchase Agreement.  Capitalized terms used herein and not otherwise defined shall have the meaning set forth in the Purchase Agreement.
 
Default.  If (a) the interest hereon or any commitment or other fee shall not be paid in full punctually when due and payable, and/or (b) the principal hereof shall not be paid in full punctually when due and payable, it shall constitute an Event of Default (“Event of Default”) under this Note.  Upon an Event of Default, or at any time thereafter, at the option of the Lender, all obligations hereunder shall become immediately due and payable without notice or demand and the Lender shall then have in any jurisdiction where enforcement hereof is sought.  All rights and remedies of the Lender are cumulative and are not exclusive of any rights or remedies provided by laws or any other agreement, and may be exercised separately or concurrently.
 
Waiver; Amendment.  No delay or omission on the part of the Lender in exercising any right hereunder shall operate as a waiver of such right or of any other right under this Note.  No waiver of any right contained in, consent to any departure from, or amendment to any provision contained in this Note shall be effective unless in writing and signed by the Lender, nor shall a waiver on one occasion be construed as a waiver of any such right on any future occasion.  Without limiting the generality of the foregoing, the acceptance by the Lender of any late payment shall not be deemed to be a waiver of the Event of Default arising as a consequence thereof.  The Borrower waives presentment, demand, notice, protest and all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Note and assents to any extensions or postponements of the time of payment or any and all other indulgences under this Note, or to any and all additions or releases of any other parties or persons primarily or secondarily liable under this Note, which from time to time be granted by the Lender in connection herewith regardless of the number or period of any extensions.
 
 
 

 
 
Governing Law; Consent to Jurisdiction.  This Note shall be governed by, and construed in accordance with, the laws of the State of New York without regard to any conflict of laws provisions that might result in the application of the laws of another state.  The Borrower agrees that any suit for the enforcement of this Note may be brought in the courts of the State of New York or any federal court sitting in such state and consents to the non-exclusive jurisdiction of each such court and to service of process in any such suit being made upon the Borrower by mail at the address set forth above.  The Borrower hereby waives any objection that it may now or hereafter have to the venue of any such suit or any such court or that such suit was brought in an inconvenient court.
 
WAIVER OF JURY TRIAL.  THE BORROWER AND THE LENDER, BY ITS ACCEPTANCE OF THIS NOTE, HEREBY WAIVE TRIAL BY JURY IN ANY LITIGATION IN ANY COURT WITH RESPECT TO, IN CONNECTION WITH, OR ARISING OUT OF:  (A) THIS NOTE OR ANY OTHER INSTRUMENT OR DOCUMENT DELIVERED IN CONNECTION WITH THE OBLIGATIONS HEREUNDER; (B) THE VALIDITY, INTERPRETATION, COLLECTION OR ENFORCEMENT THEREOF; OR (C) ANY OTHER CLAIM OR DISPUTE HOWEVER ARISING BETWEEN THE BORROWER AND THE LENDER.
 
Severability; Authorization to Complete; Paragraph Headings.  If any provision of this Note shall be invalid, illegal or unenforceable, such provision shall be severable from the remainder of this Note and the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.  Paragraph headings are for the convenience of reference only and are not a part of this Note and shall not affect its interpretation.All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural, as the identity of the person, persons, entity or entities may require.  The terms “herein,” “hereof” or “hereunder” or similar terms used in this Note refer to this entire Note and not only to the particular provision in which the term is used.
 
Assignments.  Neither this Note nor the proceeds hereof shall be assignable by the Borrower without the Lender’s prior written consent, and any attempted assignment without the Lender’s prior written consent shall create a default under this Note.  This Note may be assigned, in whole or in part, by the Lender and its successors or assigns.  The Borrower’s consent shall not be required for any such assignment.
 
IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered as of the date first above written.

 
BEIJING YI  TANG BIO SCIENCE & TECHNOLOGY, LTD.
 
 
By:       /s/ Bai Ge                  
Name: Bai Ge
Title:   President